摘要
目的探讨心肌肌钙蛋白T对婴幼儿危重病预后估计的价值。方法将63例住院患儿分成极危重组(n=11)、危重组(n=26)和非危重组(n=26),以金标法于住院第1天及第7天对三组患儿进行CTnT的定性检测。结果第1天三组患儿CTnT的阳性率分别为90.9%(10/11)、50.0%(13/26)和0(0/26),三者有显著性差异(P<0.01);第7天三组的阳性率分别为14.3%(1/7)、3.8%(1/26)、0,三者无显著性差异(P>0.05)。结论CTnT可早期对危重病例患儿的预后作初步评估,而金标法因操作简易,价格低廉,适宜基层医院推广。
Objective To investigate the clinical value of CTnT in the prognosis of critical illness. Methods Znfands and children were divided into severe critical group（n=11）, critical group（n=26） and noncritical group（n=26） according to the pediatric critical illness score （PCIS）. Gold-labelled assay was adopted to detect the serum levels of CTnT qualitatively at the first day and the seventh day to the three groups. Results The positive rates of CTnT were 90.9%（10/11）, 50.0%（13/26） and 0 in the first day respectively,there were statistically significant differences between the three groups（P〈0.01）. The positive rates of CTnT were 14.3%（1/7）, 3.8%（1/26） and 0 in the seventh day respectively, no statistically significant differences between the three groups（P〉0.05）. Conelusion CTnT can evaluate the prognosis of critical illness in early stage. Cold-labelled assay is suitable for basle hospitals with its easily operation and cheap prices.
出处
《中国现代医生》
2008年第24期46-47,共2页
China Modern Doctor
